TY  - GEN
AU  - Makhoul,Issam
AU  - Griffin,Robert J
AU  - Siegel,Eric
AU  - Lee,Jeannette
AU  - Dhakal,Ishwori
AU  - Raj,Vinay
AU  - Jamshidi-Parsian,Azemat
AU  - Klimberg,Suzanne
AU  - Hutchins,Laura F
AU  - Kadlubar,Susan
TI  - High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer
SN  - 1537-453X
PY  - 2017///0724
KW  - Angiopoietin-1
KW  - blood
KW  - Angiopoietin-2
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Becaplermin
KW  - Bevacizumab
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - Breast Neoplasms
KW  - chemistry
KW  - Carcinoma, Ductal, Breast
KW  - Chemotherapy, Adjuvant
KW  - Cyclophosphamide
KW  - Docetaxel
KW  - Doxorubicin
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - Humans
KW  - Interleukin-1alpha
KW  - Matrix Metalloproteinase 9
KW  - Neoadjuvant Therapy
KW  - Neovascularization, Pathologic
KW  - drug therapy
KW  - Platelet Endothelial Cell Adhesion Molecule-1
KW  - Platelet-Derived Growth Factor
KW  - metabolism
KW  - Prospective Studies
KW  - Proto-Oncogene Proteins c-sis
KW  - Receptor, ErbB-2
KW  - analysis
KW  - Receptor, TIE-2
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Taxoids
KW  - Vascular Endothelial Growth Factor A
KW  - Vascular Endothelial Growth Factor Receptor-2
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1097/COC.0000000000000046
ER  -